SeaStar Medical is trading at $3.66, +5.17%, with no clear company-specific announcement identified for September 18, 2026.

  • Its latest official release concerns the September 10 presentation announcement.
  • The September 11–16 HC Wainwright presentation highlighted adult-trial enrollment above 65% and a potential October 1 CMS billing-code catalyst, but predates today’s move.
  • Major indexes were modestly lower, leaving the immediate catalyst unclear.